Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034067 (
emphysema
)
11,506
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We report on a 2-year-old Japanese boy with early-onset pulmonary
emphysema
, exhibiting dysmorphic face, loose skin, and inguinal and Morgagni hernias. He was admitted to our hospital owing to refractory respiratory infection. On the basis of his clinical features, we investigated the
SLC2A10
gene and identified novel compound heterozygous mutations of c.417T > A and c.692G > A, leading to the diagnosis of artery tortuosity syndrome (ATS). This syndrome is an extremely rare autosomal recessive disorder characterized by tortuosity and elongation of the large and medium-sized arteries, hyperextensible skin, and diverse hernias, mostly reported from Europe and Middle Eastern countries, but not from Asia. Although chronic obstructive pulmonary disease, namely,
emphysema
, has not been well documented in ATS, it may be likely because TGF-beta up-regulation is known to be evoked by
SLC2A10
mutations, resulting in reconstruction of pulmonary endothelial cells and
emphysema
. This is the first report of ATS associated with early-onset pulmonary
emphysema
, suggesting that patients with ATS may also require close attention for chronic obstructive pulmonary disease.
...
PMID:Artery tortuosity syndrome exhibiting early-onset emphysema with novel compound heterozygous SLC2A10 mutations. 2349 79